Search Results - michael+trent

1 Results Sort By:
Producing modified lipid A bacterial vaccine components
Engineered bacteria are designed to produce modified lipid A with reduced toxicity and either polypeptide or polysaccharide antigens, which can be used in vaccines to elicit targeted immune responses. Background The challenge of developing effective vaccines against bacterial infections lies in the dual necessity of eliciting a robust immune response...
Published: 9/13/2024   |   Inventor(s): Michael Trent, Joseph Boll
Keywords(s):  
Category(s): Life sciences > Metabolic engineering, Life sciences > Therapeutics > Vaccines